About Phosphatidylcholine-sterol acyltransferase
Phosphatidylcholine-sterol acyltransferase (LCAT) is a protein
from Homo sapiens identified by UniProt accession
P04180, 440 residues long.
MolForge cross-references it against 0 known binders and
450 disease associations.
Target properties
| Protein name | Phosphatidylcholine-sterol acyltransferase |
| UniProt accession | P04180 |
| Gene | LCAT |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (450)
Diseases linked to this target (Open Targets).
- Fish-eye disease · score 0.82
- Norum disease · score 0.80
- Familial LCAT deficiency · score 0.76
- high density lipoprotein cholesterol measurement · score 0.68
- fish eye disease · score 0.67
- LCAT deficiency · score 0.66
- lipoprotein measurement · score 0.59
- phospholipids:total lipids ratio · score 0.59
- cholesteryl ester measurement · score 0.57
- cholesterol to total lipids in medium HDL percentage · score 0.57
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P04180-F1 | alphafold | PREDICTED | 86.78 | — |
Amino-acid sequence (440 residues)
MGPPGSPWQW VTLLLGLLLP PAAPFWLLNV LFPPHTTPKA ELSNHTRPVI LVPGCLGNQL EAKLDKPDVV NWMCYRKTED FFTIWLDLNM FLPLGVDCWI DNTRVVYNRS SGLVSNAPGV QIRVPGFGKT YSVEYLDSSK LAGYLHTLVQ NLVNNGYVRD ETVRAAPYDW RLEPGQQEEY YRKLAGLVEE MHAAYGKPVF LIGHSLGCLH LLYFLLRQPQ AWKDRFIDGF ISLGAPWGGS IKPMLVLASG DNQGIPIMSS IKLKEEQRIT TTSPWMFPSR MAWPEDHVFI STPSFNYTGR DFQRFFADLH FEEGWYMWLQ SRDLLAGLPA PGVEVYCLYG VGLPTPRTYI YDHGFPYTDP VGVLYEDGDD TVATRSTELC GLWQGRQPQP VHLLPLHGIQ HLNMVFSNLT LEHINAILLG AYRQGPPASP TASPEPPPPE
Explore Phosphatidylcholine-sterol acyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets